TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
CARL

Carlsmed, Inc.

Healthcare · Health Information Services

15.40$ +0.5% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Carlsmed, Inc. (CARL)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 57.3% of the shares are freely tradable; institutional investors hold 39.7%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 39.7%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 43.7%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 57.3%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 10.8%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 27Mio.

Largest Shareholders

Institutions

Institutions CARL
Name Stake (%) Shares Change (%) Date
Orbimed Advisors LLC 4.59 1,252,600 +0.0 03/31/2026
HHG PLC 4.50 1,227,452 +7.6 03/31/2026
Parkman Healthcare Partners LLC 2.19 597,318 +14.6 06/30/2026
BlackRock Inc 1.64 446,892 +4.5 03/31/2026
KCM Capital Inc 1.61 440,000 +120.0 06/30/2026
Pier Capital, LLC 1.37 373,677 +0.0 06/30/2026
Millennium Management LLC 1.08 295,907 +0.0 06/30/2026

Funds

Funds CARL
Name Stake (%) Shares Change (%) Date
Janus Henderson Venture D 2.24 611,231 +0.4 08/31/2026
Janus Henderson US Small Cap Growth 2.23 609,059 +3.6 06/30/2026
Janus Henderson Small Cap Value L 1.26 343,579 +0.0 06/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?